The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
983.57MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
4.50x
Updated Oct 28, 2026
Revenue (TTM)
2.47BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
9.97%
Updated Oct 28, 2026
52-Week Change
-60.05%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
983.57MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
-238.88MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Trailing P/E
4.50x
Updated Oct 28, 2026
Forward P/E
2.83x
Updated Oct 28, 2026
PEG Ratio
0.0284x
Updated Oct 28, 2026
Price to Sales (TTM)
0.0850x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.4×.Updated Oct 28, 2026
Price to Book (MRQ)
0.9000x
Updated Oct 28, 2026
Enterprise to Revenue
-0.0970x
Updated Oct 28, 2026
Enterprise to EBITDA
-0.2360x
Updated Oct 28, 2026
Profit Margin
9.97%
Updated Oct 28, 2026
Operating Margin
42.92%
Updated Oct 28, 2026
Return on Assets (TTM)
2.60%
Updated Oct 28, 2026
Return on Equity (TTM)
28.06%
Updated Oct 28, 2026
Revenue (TTM)
2.47BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
103.99USDUpdated Oct 28, 2026
Quarterly Revenue Growth
67.00%
Updated Oct 28, 2026
Gross Profit (TTM)
2.07BUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
1.01BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
246.77MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
159.60%
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-104.35MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
Updated Oct 28, 2026
Minority Interest (Equity)
17.13MBRLFY2025 · Dec 31, 2025
Revenue
6.28BBRLFY2025 · Dec 31, 2025
Pre-tax Income
317.34MBRLFY2025 · Dec 31, 2025
Income Tax Expense
-824.27MBRLFY2025 · Dec 31, 2025
Net Income
1.14BBRLFY2025 · Dec 31, 2025
Selling, General & Administrative
2.25BBRLFY2025 · Dec 31, 2025
EPS (Basic)
8.81BRLFY2025 · Dec 31, 2025
EPS (Diluted)
8.81BRLFY2025 · Dec 31, 2025
Basic Shares Outstanding
129.59MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
129.59MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
1.14BBRLFY2025 · Dec 31, 2025
Minority Interests (P&L)
-50.12MBRLFY2025 · Dec 31, 2025
Operating Cash Flow
6.04BBRLFY2025 · Dec 31, 2025
Free Cash Flow
5.97BBRLDerived from operating cash flow minus capital expenditure. This filing charges 442.76M of depreciation against 67.68M of capital expenditure, and its own free-cash-flow line reads -4.42B.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
3.86BBRLFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
1.14BBRLFY2025 · Dec 31, 2025
Depreciation & Amortization
442.76MBRLFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-824.27MBRLFY2025 · Dec 31, 2025
Stock-based Compensation
205.64MBRLFY2025 · Dec 31, 2025
Other Non-cash Items
-2.64BBRLFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-1.93BBRLFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
2.50BBRLFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
7.14BBRLFY2025 · Dec 31, 2025
Capital Expenditures
-67.68MBRLFY2025 · Dec 31, 2025
Net Intangibles (CF)
-616.66MBRLFY2025 · Dec 31, 2025
Net Acquisitions
0.00BRLFY2025 · Dec 31, 2025
Purchase of Investments
0.00BRLFY2025 · Dec 31, 2025
Net Investing Cash Flow
-67.68MBRLFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.96MBRLFY2025 · Dec 31, 2025
Other Financing Charges
-360.00MBRLFY2025 · Dec 31, 2025
Net Financing Cash Flow
815.41MBRLFY2025 · Dec 31, 2025
Shares Outstanding
129.59MSharesUpdated Oct 28, 2026
Float Shares
33.21MSharesUpdated Oct 28, 2026
Shares Short
1.50MSharesUpdated Oct 28, 2026
Short Ratio
3.34days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
4.73%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 1.16%.Updated Oct 28, 2026
% Held by Insiders
50.48%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
32.59%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
1.21BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
50.73USDUpdated Oct 28, 2026
Total Debt (MRQ)
639.52MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.5477x
Updated Oct 28, 2026
Current Ratio (MRQ)
0.9990x
Updated Oct 28, 2026
Book Value per Share (MRQ)
9.76USDUpdated Oct 28, 2026
Total Assets
41.99BBRL
7.55B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Liabilities
38.10BBRLFY2025 · Dec 31, 2025
Cash
2.29BBRLFY2025 · Dec 31, 2025
Cash Equivalents
0.00BRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents
5.70BBRLFY2025 · Dec 31, 2025
Other Short-term Investments
978.29MBRLFY2025 · Dec 31, 2025
Accounts Receivable
4.15BBRLFY2025 · Dec 31, 2025
Accounts Payable
5.50BBRLFY2025 · Dec 31, 2025
Short-term Debt
10.66MBRLFY2025 · Dec 31, 2025
Long-term Debt
850.06MBRLFY2025 · Dec 31, 2025
Retained Earnings
1.15BBRLFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.89BBRL
699.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.50USDUpdated Oct 28, 2026
52-Week High
19.95USDUpdated Oct 28, 2026
52-Week Change
-60.05%
vs all stocks
Updated Oct 28, 2026
50-Day MA
10.97USDUpdated Oct 28, 2026
200-Day MA
12.11USDUpdated Oct 28, 2026
Avg 10-Day Volume
758.60KSharesUpdated Oct 28, 2026
Avg 30-Day Volume
648.54KSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
1.95USDUpdated Oct 28, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.